CRIMX | VMCPX | CRIMX / VMCPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 14 years | - |
Gain YTD | 12.714 | 17.350 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 100000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 380M | 175B | 0% |
Annual Yield % from dividends | 1.04 | 1.51 | 69% |
Returns for 1 year | 17.89 | 28.30 | 63% |
Returns for 3 years | -15.02 | 5.05 | -297% |
Returns for 5 years | 21.53 | 59.06 | 36% |
Returns for 10 years | -22.47 | 128.12 | -18% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GEQIX | 16.52 | -0.07 | -0.42% |
Glenmede Equity Income | |||
DMIDX | 32.61 | -0.35 | -1.06% |
BNY Mellon MidCap Index I | |||
BPSCX | 28.13 | -0.34 | -1.19% |
Boston Partners Small Cap Value II Inv | |||
TNRAX | 18.13 | -0.38 | -2.05% |
1290 Avantis U.S. Large Cap Growth A | |||
FTHCX | 90.70 | -2.17 | -2.34% |
Fidelity Advisor Technology C |